Uses of human Zven antagonists

Details Uses of human Zven antagonists Uses of human Zven antagonists

2007-04-17

2007-04-17

Nickol, Gary (Department: 1646)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

10680755

ABSTRACT:
The present invention provides methods of using Zven1 and Zven2 polypeptides to increase chemokine production. The present invention also provides methods of using antagonists to Zven1 and Zven2 to treat inflammation in the intestine.

REFERENCES:
patent: 5891720 (1999-04-01), Moore et al.
patent: 6485938 (2002-11-01), Sheppard et al.
patent: 6756479 (2004-06-01), Sheppard et al.
patent: 6828425 (2004-12-01), Sheppard et al.
patent: 2002/0115610 (2002-08-01), Zhou et al.
patent: 2004/0162238 (2004-08-01), Thompson et al.
patent: 2005/0153322 (2005-07-01), Sheppard et al.
patent: 2005/0214800 (2005-09-01), Sheppard et al.
patent: WO99/06550 (1999-02-01), None
patent: WO99/63088 (1999-12-01), None
Fedi, et al., “Isolation and Characterizatin of the Human Dkk-1 Homologue, a Novel Inhibitor of Mammalian Wnt Signaling,”J. Biol. Chem. 274(27):19465-19472, Jul. 2, 1999.
Hsieh et al., “A new secreted protein that binds to Wnt proteins and inhibits their activities,”Nature 398:431-436, Apr. 1, 1999.
Jilek et al., “Murine Bv8 gene maps near a synteny breakpoint of mouse chromosome 6 and human 3p21,”Gene 256:189-195, 2000.
Li et al., “Identification of Two Prokineticin cDNAs: Recombinant Proteins Potently Contract Gastrointestinal Smooth Muscle,”Molec. Pharmacol. 59(4):692-698, Apr. 2001.
Weschelberger et al., “The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes,”FEBS Lett. 462: 177-181, 1999.
EMBL Database Accession No. AF182069, Oct. 2, 2000.
EMBL Database Accession No. AF333024, May 5, 2001.
EMBL Database Accession No. AF333025, May 5, 2001.
EMBL Database Accession No. AF182066, Dec. 14, 1999.
International Search Report for application No. PCT/US00/31278.
Schweitz et al., “MIT1, a black mamba toxin with a new and highly potent activity on intestinal contraction,”FEBS Lett 461: 183-188, 1999.
Boisbouvier et al., “A Structural Homologue of Colipase in Black Mamba Venom Revealed by NMR Floating Disulphide Bridge Analysis,”J. Mol. Biol. 283:205-219, 1998.
Joubert et al., “The Amino Acid Sequence of Protein A fromDendroaspis polylepis polylepis(Black mamba) Venom,”Hoppe-Seyler's Z. Physiol. Chem Bd.361:1787-1794, Dec. 1980.
Morrison et al., “Genetically Engineered Antibody Molecules.”Advances in Immunology 44:65-92, 1989.
Harlow and Lane, “Antibodies A Laboratory Manual,”Cold Spring Harbor Laboratory, pp. 76, 361, 476, 555 and 626, 1988.

Affiliated with

Also associated with

Rating

Uses of human Zven antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses of human Zven antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of human Zven antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3806708